Skip to main content
. 2020 Nov 3;14(1):100932. doi: 10.1016/j.tranon.2020.100932

Fig. 3.

Fig. 3

Platelet-to-lymphocyte ratios (PLRs) and circulating tumor microemboli (CTM) in non-metastatic colon cancer. (A) Comparison of DFS between patients with low PLRs (<124) versus those with high PLRs (≥124) at C1 (p = 0.01). (B) Distribution of PLR levels among patients with versus without CTM, by pS (stages I and low-risk II: p = 0.16; high-risk stage II and stage III). (C) Among patients with CTM (N = 10), PLRs were higher in patients with right-sided colon cancer (p = 0.01 vs. left-sided).